Terms: = Lymphoma AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10
18 results:
1. Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation.
Sala M; Allain N; Moreau M; Jabouille A; Henriet E; Abou-Hammoud A; Uguen A; Di-Tommaso S; Dourthe C; Raymond AA; Dupuy JW; Gerard E; Dugot-Senant N; Rousseau B; Merlio JP; Pham-Ledart A; Vergier B; Tartare-Deckert S; Moreau V; Saltel F
Oncogene; 2022 Apr; 41(18):2571-2586. PubMed ID: 35322197
[TBL] [Abstract] [Full Text] [Related]
2. [The imaging signs and significances of the enlargement of the infraorbital nerve and the frontal nerve in orbital lymphoproliferative diseases].
Wang Y; Zhuo W; Hei Y; Tong QZ; Li TY
Zhonghua Yan Ke Za Zhi; 2020 Nov; 56(11):832-838. PubMed ID: 33152841
[No Abstract] [Full Text] [Related]
3. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.
Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW
Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970
[TBL] [Abstract] [Full Text] [Related]
4. Circ-LAMP1 promotes T-cell lymphoblastic lymphoma progression via acting as a ceRNA for miR-615-5p to regulate ddr2 expression.
Deng L; Liu G; Zheng C; Zhang L; Kang Y; Yang F
Gene; 2019 Jun; 701():146-151. PubMed ID: 30922709
[TBL] [Abstract] [Full Text] [Related]
5. Primary and Metastatic Melanoma With NTRK Fusions.
Lezcano C; Shoushtari AN; Ariyan C; Hollmann TJ; Busam KJ
Am J Surg Pathol; 2018 Aug; 42(8):1052-1058. PubMed ID: 29683819
[TBL] [Abstract] [Full Text] [Related]
6. Targeted therapy in nonsmall cell lung cancer.
Puri T
Indian J Cancer; 2017; 54(1):83-88. PubMed ID: 29199670
[TBL] [Abstract] [Full Text] [Related]
7. Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
Dey N; Krie A; Klein J; Williams K; McMillan A; Elsey R; Sun Y; Williams C; De P; Leyland-Jones B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590426
[TBL] [Abstract] [Full Text] [Related]
8. Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and ddr2 in primary pulmonary adenoid cystic carcinoma.
Huo Z; Wu H; Li S; Liang Z
Diagn Pathol; 2015 Sep; 10():161. PubMed ID: 26373952
[TBL] [Abstract] [Full Text] [Related]
9. Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.
Califano R; Abidin A; Tariq NU; Economopoulou P; Metro G; Mountzios G
Cancer Treat Rev; 2015 May; 41(5):401-11. PubMed ID: 25842168
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and predictive biomarkers in lung cancer. A review.
Thunnissen E; van der Oord K; den Bakker M
Virchows Arch; 2014 Mar; 464(3):347-58. PubMed ID: 24420742
[TBL] [Abstract] [Full Text] [Related]
11. From platinum compounds to targeted therapies in advanced thoracic malignancies.
Jakopovic M; Thomas A; Lopez-Chavez A
Anticancer Res; 2014 Jan; 34(1):477-82. PubMed ID: 24403504
[TBL] [Abstract] [Full Text] [Related]
12. Emerging protein kinase inhibitors for non-small cell lung cancer.
Liu SV; Subramaniam D; Cyriac GC; Abdul-Khalek FJ; Giaccone G
Expert Opin Emerg Drugs; 2014 Mar; 19(1):51-65. PubMed ID: 24354593
[TBL] [Abstract] [Full Text] [Related]
13. [Advances of molecular targeted therapy in squamous cell lung cancer].
Ma L; Zhang S
Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):671-5. PubMed ID: 24345494
[TBL] [Abstract] [Full Text] [Related]
14. Targeted therapy for NSCLC with driver mutations.
Minuti G; D'Incecco A; Cappuzzo F
Expert Opin Biol Ther; 2013 Oct; 13(10):1401-12. PubMed ID: 23930754
[TBL] [Abstract] [Full Text] [Related]
15. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract] [Full Text] [Related]
16. New targetable oncogenes in non-small-cell lung cancer.
Oxnard GR; Binder A; Jänne PA
J Clin Oncol; 2013 Mar; 31(8):1097-104. PubMed ID: 23401445
[TBL] [Abstract] [Full Text] [Related]
17. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract] [Full Text] [Related]
18. Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma.
Renné C; Willenbrock K; Küppers R; Hansmann ML; Bräuninger A
Blood; 2005 May; 105(10):4051-9. PubMed ID: 15677564
[TBL] [Abstract] [Full Text] [Related]